Active Citizenship Network (ACN) is glad to invite you on the 17 of December 2021 from 11.00 to 12.30 CET to the event titled “Addressing the challenges of concomitant deployment of COVID-19 and influenza vaccination”.REGISTER HERE
It will be held in the framework of the cycle of EU Webinars «Health at the heart of the future of Europe», which ACN is holding to feed the debate of the Conference for the Future of Europe and it will include the presentation of the results of the II Survey realized in different EU countries for the project: Protecting the value of vaccination during -and after- the COVID-19 pandemic across Europe: impact, experiences and perspectives from citizens’ and patients’ advocacy groups & relevant stakeholders.
It will discuss the different national experiences of this new FLU (INFLUENZA) vaccination campaign and the concomitant deployment of COVID-19 vaccination, with concrete suggestions from patient organizations, health care professionals, and EU and national institutions.
This multi-stakeholder event (civil society, patients, experts, institutions) has the aim to discuss the survey results: a reflection moment, a confrontation between the involved stakeholders to understand if there are common aspects observed, good and bad practices, and to find proposals.
Why a webinar? The aim is to build a broad picture of this challenging moment in different countries. Moreover, to identify, thanks to the discussion and to the online questionnaire compiled, the main issues and recommendations that emerged from the information gathered; demonstrate what this community can offer in terms of raising awareness about the phenomenon, enhancing the body of knowledge of positive cases and successful experiences, and strengthening commitment to this topic.
We won’t collect statistical data, but we use the survey as a sort of “online focus group” (that we cannot carry out in person) to bring out the opinions and concerns of the various stakeholders involved, in the different countries. Join us HERE!
For more information, please write to
To know more:
